Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl patents


Recent patent applications related to xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl. xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl is listed as an Agent/Assignee. Note: xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl may have other listings under different names/spellings. We're not affiliated with xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory " " | xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl-related inventors


Erythrocyte-binding therapeutics

Peptides that specifically bind erythrocytes are described. These are provided as peptidic ligands having sequences that specifically bind, or as antibodies or fragments thereof that provide specific binding, to erythrocytes. The peptides may be prepared as molecular fusions with therapeutic agents, tolerizing antigens, or targeting peptides. Immunotolerance may be created... xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl

Benzimidazole sulfide derivatives for the treatment or prevention of tuberculosis

The present invention relates to the use of benzimidazole sulfide derivatives and prodrugs thereof in the treatment and/or prevention of tuberculosis.... xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl

Benzothiophene, benzyloxybenzylidene and indoline derivatives useful for the treatment of tuberculosis

The present invention relates to benzothiophene, benzyloxybenzylidene and indoline-2-one derivatives and the use of said derivatives in the treatment and/or prevention of tuberculosis.... xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl

Erythrocyte-binding therapeutics

Peptides that specifically bind erythrocytes are described. These are provided as peptidic ligands having sequences that specifically bind, or as antibodies or fragments thereof that provide specific binding, to erythrocytes. The peptides may be prepared as molecular fusions with therapeutic agents, tolerizing antigens, or targeting peptides. Immunotolerance may be created... xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl

Glycotargeting therapeutics

Several embodiments of the present disclosure relate to glycotargeting therapeutics that are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. Methods... xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for xc9 cole Polytechnique F xe9 d xe9 rale De Lausanne epfl with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###